This week's episode features two very different topics. Patrick Chovanec of Silvercrest Asset Management joins Cardiff Garcia and Matt Klein to discuss devaluation of the renminbi and other imbalances in the Chinese economy. FT correspondents Shannon Bond and David Crow examine concerns raised over Flibanserin, the newly approved drug for hypoactive sexual desire disorder.

iTunes Stitcher audioBoom SoundCloud Overcast RSS


Copyright The Financial Times Limited 2017. All rights reserved.
myFT

Follow the topics related to this show

Comments have not been enabled for this podcast.